The Academy of Oncology Nurse & Patient Navigators (AONN+) Applauds the Centers for Medicare & Medicaid Services for Including Reimbursement for Oncology Patient Navigation in CY24 Medicare Physician Fee Schedule Proposal

Navigation & Survivorship News published on July 20, 2023 in News & Updates

In recognition of the recent announcement by the Centers for Medicare & Medicaid Services (CMS) proposing payment for community health integration services, the Academy of Oncology Nurse & Patient Navigators (AONN+) sees this opportunity as a key initiative to strengthen and accelerate the oncology navigation footprint in every community. These services are often completed by patient navigators and Principal Illness Navigation services but can be accomplished by all professional navigator types to help patients traverse cancer treatment and treatment for other serious illnesses. The provisions described by the proposed codes are groundbreaking as the first that are specifically designed to describe services of navigators that focus daily on what is best for the patient and caregivers through person-centered planning, care coordination, patient empowerment, and addressing individual barriers to promote access to care and treatment. This is a monumental commitment to health equity as navigation is an evidence-based solution to addressing disparities in cancer care. As the professional home dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of all oncology navigators, AONN+ is excited to see the recognition of the navigation metric contributions that are completed through patient outcomes, return on investment, and patient satisfaction. AONN+ thanks CMS for seeing the value of patient navigation services and is in full support of advancing this initiative.

Since 2019, the AONN+ Leadership Council has made it part of their strategic plan to support a sustainable navigation workforce, and reimbursement for services was one part of the vision. Other strategies included identifying metrics important to payors to compensate for navigation via bundled payments or other alternative payment/value-based models, and to encourage buy-in from organizational leadership to use metrics in the operationalization of navigation services that show systemic value in a patient-centric model.

AONN+ is alerting all members that they can submit comments on the CY 2024 Medicare Physician Fee Schedule Proposed Rule by visiting the following link: https://www.regulations.gov/ (in commenting please refer to file code CMS-1784-P in the search) or you can also visit: https://www.regulations.gov/document/CMS-2023-0121-1282. The deadline for submitting comments is September 11, 2023.

Related Items
Colorectal Cancer Screening Update: with Andi Dwyer, MPH
News & Updates published on June 23, 2026 in News & Updates
In this interview, AONN+ Board of Trustees member Andi Dwyer discusses the American Cancer Society’s updated colorectal cancer screening guidelines, including new stool-based tests and the first-ever recommendation of an FDA-approved blood-based screening test, while emphasizing that colonoscopy and stool tests remain the most effective tools for early detection and prevention.
AONN+ Joins Pfizer’s 7th Annual Advocacy Luncheon at ASCO 2026
News & Updates published on June 23, 2026 in News & Updates
Pfizer’s 7th Annual Advocacy Luncheon at ASCO 2026 brought together advocacy leaders, including AONN+ Executive Director Candice Roth, MSN, RN, CENP, to discuss emerging cancer therapies, the role of artificial intelligence in patient-centered care, and the launch of Pfizer’s new Patient Advocacy360 partnership framework.
AONN+ Takes Part in CAR T Vision Coalition Event
News & Updates published on June 23, 2026 in News & Updates
Candice Roth, MSN, RN, CENP, and Monica Dean represented AONN+ at the launch of the first U.S. CAR T Vision to Action Blueprint, a stakeholder-driven initiative that provides practical strategies and tools to address access barriers and expand the use of CAR T-cell therapy for eligible patients nationwide by 2030.